Grifols GRFS
NASDAQ GRFS
$8.00 +0.01 (+0.13%)
At close: Aug 21, 2026 · 4:00 PM EDT

Grifols (GRFS) Return on Sales Growth (3y) (2013 - 2020)

Grifols (GRFS) Return on Sales Growth (3y) (2013 - 2020) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS Growth (3y) (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn 0.00
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn 0.00
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn 0.00
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn 0.00
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn 0.00
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn 0.00
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn -2.00
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn -1.00
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn 0.00
10 Grifols 5.45 Bn 4.45 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2020 0.00
Dec 31, 2019 0.00
Mar 31, 2019 0.00
Dec 31, 2018 0.00
Sep 30, 2018 0.00
Jun 30, 2018 0.00
Mar 31, 2018 0.00
Dec 31, 2017 0.00
Jun 30, 2017 0.00
Mar 31, 2017 0.00
Dec 31, 2016 0.00
Sep 30, 2016 0.00
Jun 30, 2016 0.00
Mar 31, 2016 0.00
Dec 31, 2015 0.00
Sep 30, 2015 0.00
Jun 30, 2015 0.00
Mar 31, 2015 0.00
Dec 31, 2014 0.00
Sep 30, 2014 0.00